NLS

In the not-so-distant future, the phrase Big Pharma may be a thing of the past as pharmaceutical companies downsize and outsource more responsibilities, and work more closely with stakeholders. Even those outside the traditional pharmaceutical circle. The changes will not be easy for some companies, but it is inevitable if corporations want to remain solvent […]

Nordic Life Science Magazine had an exclusive interview with Jim Van heusden, the new CEO of Karolinska Development.

With the largest economy in central Europe, Poland is attracting a lot of interest from the Nordic life science industry. The country’s pharmaceutical, biotechnology, clinical trial and medical technology sectors all are expected to keep growing for the next several years. “Poland is a huge market of 38 million people with healthcare expenditures of 24 […]

Lundbeck LLC has initiated the CLOVER I Study to investigate the use of clobazam for the treatment of children and adolescents with Dravet syndrome — a rare and severe form of epilepsy that begins in infancy. The drug already is approved in the U.S. for seizures associated with another epilepsy syndrome.  The study is designed […]

Researchers at the University of Oslo have discovered that nerve fibers form when small vesicles inside the neuron, called endosomes, merge with the cell membrane. The cell membrane is the cell’s outer layer.  The breakthrough was made during microscopy studies at the Centre for Cancer Biomedicine (CCB). CCB is a center of excellence at the […]

An AstraZeneca drug with disappointing results against solid tumors has shown promise in the treatment of Alzheimer’s disease, according to a team at Yale University in the U.S. The drug, AZD0530, attacks one of the key steps in the development of Alzheimer’s–blocking the activation of the enzyme FYN, which interrupts the synaptic connections between brain […]